No registrations found.
ID
Source
Brief title
Health condition
Colorectal cancer
Sponsors and support
Prof. dr. Siersema, MD, PhD
Department of Gastroenterology and Hepatology
University Medical Center Utrecht
P.O. Box 85500, 3508 GA Utrecht
Heidelberglaan 100, 3584 CX Utrecht
Tel.nr.: +31 88 7555555
Fax.nr.: +31 88 755 5533
E-mail: p.d.siersema@umcutrecht.nl
Intervention
Outcome measures
Primary outcome
Investigate whether DWIBS is effective for colorectal cancer screening.
Secondary outcome
Sensitivity of DWIBS for the detection of colorectal cancer and polyps > 6mm.
Background summary
The DWIBS-sequentie is a promising MRI-techniek for the early detection of colorectal cancer. We want to investigate whether DWIBS is effective for colorectal cancer screening.
Study objective
Investigate whether DWIBS is effective for colorectal cancer screening.
Study design
Inclusion of patients: 2 years.
Intervention
1. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS);
2. Colonoscopy.
P.O. Box 85500
A. Leufkens
Department of Gastroenterology and Hepatology
University Medical Center Utrecht
Heidelberglaan 100, 3584 CX Utrecht
Utrecht 3508 GA
The Netherlands
+31 887551057 / +31 88 7555555
a.m.leufkens@umcutrecht.nl
P.O. Box 85500
A. Leufkens
Department of Gastroenterology and Hepatology
University Medical Center Utrecht
Heidelberglaan 100, 3584 CX Utrecht
Utrecht 3508 GA
The Netherlands
+31 887551057 / +31 88 7555555
a.m.leufkens@umcutrecht.nl
Inclusion criteria
1. Age 50 years or older;
2. Patients who will undergo a colonoscopy because of the suspicion of having colorectal carcinoma, with at least one of the following symptoms: rectal blood loss, altered bowel habits, unexplained weight loss, abdominal pain, and/or anemia;
3. Written informed consent.
Exclusion criteria
1. General contra-indications for MRI (metal devices [pacemakers, endoprotheses, intra uterine devices, neurostimulators, insulin pump, intra-ocular parts of metal, ear implants, artificial metal cardial valves], claustrophobia);
2. Weight >100kg;
3. A history of another malignancy;
4. Pregnant patients or patients lactating;
5. Patients in which therapy is already started.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL1527 |
| NTR-old | NTR1599 |
| Other | METC UMC Utrecht : 08-175 |
| ISRCTN | ISRCTN wordt niet meer aangevraagd |